BRIACELL THERAPEUTICS CORP (BCT.CA) Stock Income Statement
TSX:BCT - Toronto Stock Exchange - CA1079301091 - Common Stock - Currency: CAD
| TTM (2024-10-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 124.50K | 140.10K | N/A | N/A | N/A | |||
| Operating Expenses | 29.98M | 33.33M | 23.27M | 15.29M | 6.98M | |||
| Research and Development | 23.99M | 27.18M | 15.34M | 8.02M | 2.02M | |||
| Selling, General, and Administrative Expenses | 5.99M | 6.15M | 7.94M | 7.27M | 4.96M | |||
| Operating Income | -29.98M | -33.33M | -23.27M | -15.29M | -6.98M | |||
| Interest Income/Expense | 13.26M | 28.40M | 2.97M | -11.55M | -6.70M | |||
| Other Income/Expense | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | 0.00 | 3.40K | -138.00K | |||
| Income Before Taxes | -16.72M | -4.93M | -20.30M | -26.84M | -13.82M | |||
| Net Income | -16.60M | -4.79M | -20.30M | -26.84M | -13.82M | |||
| EBITDA | -29.87M | -33.25M | -23.26M | -15.27M | -6.96M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.38 | -4.37 | -19.50 | -25.98 | -3.06 | |||
| Non GAAP EPS | -4.95 | -2.15 | -1.30 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD